<DOC>
	<DOCNO>NCT01233518</DOCNO>
	<brief_summary>This prospective , multi-center trial conduct 20 US , Canadian , European Asian center design determine diagnostic performance CT-FLOW ( investigational technology ) coronary compute tomographic angiography ( CCTA ) non-invasive assessment hemodynamic significance coronary lesion , compare direct measurement fractional flow reserve ( FFR ) cardiac catheterization reference standard .</brief_summary>
	<brief_title>Determination Fractional Flow Reserve Anatomic Computed Tomographic Angiography</brief_title>
	<detailed_description>285 patient , prospective , multi-center trial conduct 20 US , Canadian , European Asian center design determine diagnostic performance CT-FLOW ( investigational technology ) coronary compute tomographic angiography ( CCTA ) non-invasive assessment hemodynamic significance coronary lesion , compare direct measurement fractional flow reserve ( FFR ) cardiac catheterization reference standard</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Age &gt; 18 year Patients provide write informed consent Scheduled undergo clinicallyindicated nonemergent invasive coronary angiography ( ICA ) Has undergone &gt; 64 multidetector row CCTA within 60 day prior ICA No cardiac interventional therapy CCTA ICA Prior coronary artery bypass graft ( CABG ) surgery Prior percutaneous coronary intervention ( PCI ) suspect coronary artery lesion ( ) within stented coronary vessel Contraindication adenosine , include 2nd 3rd degree heart block ; sick sinus syndrome ; long QT syndrome ; severe hypotension , severe asthma , , severe COPD bronchodilatordependent COPD Suspicion acute coronary syndrome ( acute myocardial infarction unstable angina ) Recent prior myocardial infarction within 40 day ICA Known complex congenital heart disease Prior pacemaker internal defibrillator lead implantation Prosthetic heart valve Significant arrhythmia tachycardia Impaired chronic renal function ( serum creatinine &gt; 1.5 mg/dl Patients know anaphylactic allergy iodinate contrast Pregnancy unknown pregnancy status Body mass index &gt; 35 Patient require emergent procedure Evidence ongoing active clinical instability , include acute chest pain ( sudden onset ) , cardiogenic shock , unstable blood pressure systolic blood pressure &lt; 90 mmHg , severe congestive heart failure ( NYHA III IV ) acute pulmonary edema Any active , serious , lifethreatening disease life expectancy le 2 month Inability comply study procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>CCTA Coronary Artery Disease CAD</keyword>
</DOC>